Ardelyx, Inc. ARDX
Regular-session close
Pre-market · Nov 19, 7:57 AM ET
- YTD
- -46.48%
- 1 year
- -46.30%
Discussion (240)
Don’t believe my words. Buy out is coming!!!
Cum on, just hit $13 so we can all move on
F yaaaa.$8
How do you know that’s a planned sale?
7% jump premarital jump. Some @holes have nothing better to do.
Price has been lingering around. Not sure if a buyout is possible.
Come on, I don’t care what your drug does. Just go up. Up up up.
Ardelyx to Host Analyst Day in New York
Management to Review Late Stage Clinical Development and Commercial Potential in Hyperphosphatemia, Pipeline Program in Hyperkalemia and Recent Approval in IBS-C
Ardelyx logo (PRNewsFoto/Ardelyx)
NEWS PROVIDED BY
Ardelyx
Oct 10, 2019, 16:00 ET
FREMONT, Calif., Oct. 10, 2019 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), today announced that it will hold an Analyst Day on Thursday, Oct. 17, 2019, from 7:30 a.m. to 11:00 a.m. ET in New York City. This year's event will focus on a review of late stage clinical development and commercial potential in hyperphosphatemia, pipeline program in hyperkalemia and the recent approval of the Company's New Drug Application for tenapanor for the treatment of IBS-C. Leading nephrologist, Myles Wolf, M.D., Chief of Nephrology, Duke University, will offer a clinician's perspective on the challenges of treating hyperphosphatemia in patients with CKD on dialysis.
Tomorrow will be down 30%
Clays here. Not good
